Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.
Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, Jay N, Aboulafia D, Cohn DL, Einstein MH, Saah A, Mitsuyasu RT, Palefsky JM.
Wilkin T, et al.
J Infect Dis. 2010 Oct 15;202(8):1246-53. doi: 10.1086/656320.
J Infect Dis. 2010.
PMID: 20812850
Free PMC article.
Clinical Trial.